Giamarellos-Bourboulis, Evangelos J.
Aschenbrenner, Anna C. http://orcid.org/0000-0002-9429-5457
Bauer, Michael http://orcid.org/0000-0002-1521-3514
Bock, Christoph http://orcid.org/0000-0001-6091-3088
Calandra, Thierry
Gat-Viks, Irit
Kyriazopoulou, Evdoxia http://orcid.org/0000-0002-9585-517X
Lupse, Mihaela
Monneret, Guillaume http://orcid.org/0000-0002-9961-5739
Pickkers, Peter
Schultze, Joachim L. http://orcid.org/0000-0003-2812-9853
van der Poll, Tom http://orcid.org/0000-0002-9199-5079
van de Veerdonk, Frank L.
Vlaar, Alexander P. J.
Weis, Sebastian http://orcid.org/0000-0003-3201-2375
Wiersinga, W. Joost http://orcid.org/0000-0003-2277-1343
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422, 847422)
Article History
Received: 4 May 2023
Accepted: 21 September 2023
First Online: 2 January 2024
Competing interests
: E.J.G.-B. has received honoraria from Abbott, bioMérieux, Brahms, GSK, InflaRx, Sobi and XBiotech, and independent educational grants from Abbott, AxisShield, bioMérieux, InflaRx, Johnson & Johnson, MSD, Sobi and XBiotech. A.V. receives consulting fees from Inflarx paid to Amsterdam UMC. M.B. is cofounder and holds shares of SmartDyeLivery, Jena. M.G.N. is a scientific founder and holds shares of TTxD, BioTRIP and Lemba. All other authors have no conflicts of interest.